Trials / Completed
CompletedNCT01590667
Effect of Litramine on Fat Excretion
Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate the Effect of Litramine on Fecal Fat Excretion in Healthy Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The study aims to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, to provide more comprehensive and robust clinical evidence in its mode of action for the treatment of obesity and weight management through dietary fat binding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Litramine | 2 tablets 3 times daily (oral consumption, 30 minutes after meal) |
| DEVICE | Placebo | 2 tablets 3 times daily (oral consumption, 30 minutes after meal) |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-05-03
- Last updated
- 2012-07-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01590667. Inclusion in this directory is not an endorsement.